Short Interest in Cibus, Inc. (NASDAQ:CBUS) Expands By 5.1%

Cibus, Inc. (NASDAQ:CBUS) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 2,050,000 shares, an increase of 5.1% from the November 15th total of 1,950,000 shares. Based on an average daily volume of 204,400 shares, the days-to-cover ratio is presently 10.0 days. Approximately 11.0% of the shares of the company are sold short.

Cibus Stock Performance

CBUS opened at $3.75 on Wednesday. The stock has a fifty day moving average of $4.18 and a 200-day moving average of $6.40. Cibus has a fifty-two week low of $2.86 and a fifty-two week high of $23.18. The company has a market capitalization of $99.21 million, a P/E ratio of -0.17 and a beta of 1.86.

Analysts Set New Price Targets

Several research firms have issued reports on CBUS. Alliance Global Partners dropped their price objective on Cibus from $25.00 to $23.50 and set a “buy” rating on the stock in a research note on Tuesday, September 24th. Canaccord Genuity Group restated a “buy” rating and set a $20.00 target price on shares of Cibus in a research note on Tuesday, October 22nd. Finally, HC Wainwright reissued a “buy” rating and issued a $25.00 price target on shares of Cibus in a report on Monday, November 11th.

Institutional Trading of Cibus

Several hedge funds and other institutional investors have recently bought and sold shares of the business. SG Americas Securities LLC bought a new position in Cibus during the 3rd quarter worth $33,000. B. Riley Wealth Advisors Inc. bought a new position in shares of Cibus in the third quarter worth $44,000. Virtu Financial LLC acquired a new position in Cibus in the third quarter valued at about $48,000. HighTower Advisors LLC lifted its position in Cibus by 20.6% during the third quarter. HighTower Advisors LLC now owns 16,125 shares of the company’s stock worth $52,000 after purchasing an additional 2,750 shares during the period. Finally, Barclays PLC grew its stake in Cibus by 287.2% during the third quarter. Barclays PLC now owns 20,269 shares of the company’s stock worth $66,000 after buying an additional 15,034 shares in the last quarter. Institutional investors and hedge funds own 33.81% of the company’s stock.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.